# Regeneron Pharmaceuticals Inc. (REGN) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | $4.50B |
| 2024 | $4.41B |
| 2023 | $3.95B |
| 2022 | $4.34B |
| 2021 | $8.08B |
| 2020 | $3.51B |
| 2019 | $2.12B |
| 2018 | $2.44B |
| 2017 | $1.20B |
| 2016 | $896M |
| 2015 | $636M |
| 2014 | $338M |
| 2013 | $414M |
| 2012 | $750M |
| 2011 | -$222M |
| 2010 | -$104M |
| 2009 | -$68M |
| 2008 | -$79M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2026-03-31 | $727M |
| 2025-09-30 | $1.46B |
| 2025-06-30 | $1.39B |
| 2025-03-31 | $809M |
| 2024-09-30 | $1.34B |
| 2024-06-30 | $1.43B |
| 2024-03-31 | $722M |
| 2023-09-30 | $1.01B |
| 2023-06-30 | $968M |
| 2023-03-31 | $818M |
| 2022-09-30 | $1.32B |
| 2022-06-30 | $852M |
| 2022-03-31 | $974M |
| 2021-09-30 | $1.63B |
| 2021-06-30 | $3.10B |
| 2021-03-31 | $1.12B |
| 2020-09-30 | $842M |
| 2020-06-30 | $897M |
| 2020-03-31 | $625M |
| 2019-09-30 | $670M |
| 2019-06-30 | $193M |
| 2019-03-31 | $461M |
| 2018-09-30 | $595M |
| 2018-06-30 | $551M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/REGN/net-income)